secwatch.observer — SEC 8-K summary
======================================

Issuer:     Aurinia Pharmaceuticals Inc. (AUPH)
CIK:        0001600620
Form:       8-K
Filed at:   2023-01-03T23:59:59+00:00
Accession:  0001628280-23-000097
Event type: litigation
Sentiment:  neutral
Materiality: 0.50
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Aurinia settles patent dispute with Sun Pharma, ends IPR and litigation
-----------------------------------------------------------------------

- Joint motion to terminate IPR on Aurinia's U.S. Patent No. 10,286,036 filed.
- Parties agree to dismiss all claims and counterclaims in patent litigation over Sun's CEQUA product.
- Settlement conditional on USPTO approval of IPR termination.
- No financial terms disclosed; both parties cease future actions.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1600620/000162828023000097/0001628280-23-000097-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1600620/000162828023000097/auph-20230103.htm
  HTML page:      https://secwatch.observer/filing/0001628280-23-000097

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer